HHLR Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Hold |
918,892
| – | – | 0.04% | 32 |
|
|
2025
Q1 | $1.08M | Hold |
918,892
| – | – | 0.03% | 41 |
|
|
2024
Q4 | $1.68M | Hold |
918,892
| – | – | 0.06% | 37 |
|
|
2024
Q3 | $1.56M | Hold |
918,892
| – | – | 0.03% | 38 |
|
|
2024
Q2 | $1.26M | Hold |
918,892
| – | – | 0.03% | 68 |
|
|
2024
Q1 | $3.45M | Hold |
918,892
| – | – | 0.07% | 39 |
|
|
2023
Q4 | $9.01M | Hold |
918,892
| – | – | 0.18% | 30 |
|
|
2023
Q3 | $7.67M | Buy |
+918,892
| New | +$7.67M | 0.17% | 39 |
|
|
2021
Q4 | – | Sell |
-911,039
| Closed | -$23.3M | – | 85 |
|
|
2021
Q3 | $23.3M | Buy |
+911,039
| New | +$23.3M | 0.3% | 42 |
|